Mitochondrial Metabolism in a Large-Animal Model of Huntington Disease: The Hunt for Biomarkers in the Spermatozoa of Presymptomatic Minipigs

Publisher： Karger

E-ISSN： 1660-2862|17|4-5|213-226

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.17, Iss.4-5, 2017-06, pp. : 213-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lessons from animal models of Huntington's disease

By Rubinsztein D.C.  

Trends in Genetics, Vol. 18, Iss. 4, 2002-04 ,pp. : 202-209

Elsevier

Access to resources Recommend Favorite

Pcaf Modulates Polyglutamine Pathology in a Drosophila Model of Huntington’s Disease

By  

Neurodegenerative Diseases, Vol. 9, Iss. 2, 2011-09 ,pp. : 104-106

Karger

Access to resources Recommend Favorite

N-Acetylcysteine Reverses Mitochondrial Dysfunctions and Behavioral Abnormalities in 3-Nitropropionic Acid-Induced Huntington’s Disease

By  

Neurodegenerative Diseases, Vol. 9, Iss. 3, 2012-02 ,pp. : 145-157

Karger

Access to resources Recommend Favorite

Anti‐inflammatory compounds to reduce infarct size in large‐animal models of myocardial infarction: A meta‐analysis

By  

Evidence-Based Preclinical Medicine, Vol. 1, Iss. 1, 2014-12 ,pp. : 4-10

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mitochondrial Inhibitor Models of Huntington’s Disease and Parkinson’s Disease Induce Zinc Accumulation and Are Attenuated by Inhibition of Zinc Neurotoxicity in vitro or in vivo

By  

Neurodegenerative Diseases, Vol. 11, Iss. 1, 2012-05 ,pp. : 49-58

Karger

Access to resources Recommend Favorite